Supply Chain Business Continuity

RISK MANAGEMENT

Supply Chain

Assess your risks and minimize downtime if disaster strikes.

Plan for an uninterrupted business plan

What would happen to your business if a key shipment were delayed? Or a fire destroyed your biggest supplier of materials?

The risks are real, and Lockton’s Business Continuity experts will help you assess them. Then we’ll establish contingencies to minimize downtime so that the answer is “yes” – your business will survive if disaster strikes.

Business Continuity Planning (BCP) ensures the continuation of operations in the event of a catastrophic event.  Through Lockton’s BCP disaster recovery planning, we will work with you to identify the actions, resources, and procedures that will help keep your business operational despite unexpected interruptions.

Deep analysis of your business risks and interruptions

In addition to a disaster recovery plan, Lockton’s experts will help you conduct a thorough review of your supply chain – starting by identifying the products and services that are essential to your business. We will:

  • Evaluate potential threats to essential services, then establish a Recovery Time Objective (RTO) for each essential service.

  • Play “what if?” to develop plan contingencies.

  • Appoint an executive-level team to develop a corporate global plan, including a method to update risk assessment and contingency plans.

Latest news & insights

The worldwide shift to remote work has sparked new logistical and structural legal challenges that have warranted many countries to pass teleworking legislation. This article has been updated to include recent amendments to Ukraine’s home-based and remote working legislation from 2 May 2025.New Remote Working Legislation Around the World [Updated]

Common crime insurance losses for private equity portfolio companies

Learn how private equity portfolio companies can mitigate employee theft, fraud, and crime-related financial losses.Learn how private equity portfolio companies can mitigate employee theft, fraud, and crime-related financial losses.

Cell & gene therapy: Preparing for the next phase of employer health plan risk

Cell and gene therapies remain rare for most employer health plans today, but expanding treatment access and new indications may increase exposure in the years ahead.Cell and gene therapies remain rare for most employer health plans today, but expanding treatment access and new indications may increase exposure in the years ahead.

Reminder: PCORI filing due July 31

The Patient-Centered Outcomes Research Institute filing and payment to the IRS is due by July 31, 2026, and applies to policy and plan years ending during the 2025 calendar year.
The Patient-Centered Outcomes Research Institute filing and payment to the IRS is due by July 31, 2026, and applies to policy and plan years ending during the 2025 calendar year.
View All news and insights